A twist in anti-inflammation: Annexin 1 acts via the lipoxin A4 receptor

Gallin, 1992, Overview, 1 Panés, 1999, Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention, Br. J. Pharmacol., 126, 537, 10.1038/sj.bjp.0702328 Perretti, 1997, Endogenous mediators that inhibit the leukocyte-endothelium interaction, Trends Pharmacol. Sci., 18, 418 Mosser, 2003, The many faces of macrophage activation, J. Leukoc Biol., 73, 209, 10.1189/jlb.0602325 Liu, 1999, Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes, J. Immunol., 162, 3639 Gilroy, 2004, Inflammatory resolution: new opportunities for drug discovery, Nat. Rev. Drug Discov., 3, 401, 10.1038/nrd1383 Cronstein, 1995, Targets for antiinflammatory drugs, Ann. Rev. Pharmacol. Toxicol., 35, 449, 10.1146/annurev.pa.35.040195.002313 Gilroy, 1999, Inducible cyclooxygenase may have anti-inflammatory properties, Nat. Med., 5, 698, 10.1038/9550 Lawrence, 2001, Possible new role for NF-kappaB in the resolution of inflammation, Nat. Med., 7, 1291, 10.1038/nm1201-1291 Perretti, 2003, Annexin 1: an endogenous anti-inflammatory protein, News Physiol. Sci., 18, 60 Flower, 1988, Lipocortin and the mechanism of action of the glucocorticoids, Br. J. Pharmacol., 94, 987, 10.1111/j.1476-5381.1988.tb11614.x Perretti, 1998, Lipocortin 1 and chemokine modulation of granulocyte and monocyte accumulation in experimental inflammation, Gen. Pharmacol., 31, 545, 10.1016/S0306-3623(98)00039-1 Yang, 2003, Modulation of inflammation and response to dexamethasone by annexin-1 in antigen-induced arthritis, Arthritis Rheum. Hannon, 2003, Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse, FASEB J., 17, 253, 10.1096/fj.02-0239fje Minghetti, 1999, Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase by lipocortin 1, Br. J. Pharmacol., 126, 1307, 10.1038/sj.bjp.0702423 Croxtall, 1992, Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line, Proc. Natl. Acad. Sci. USA, 89, 3571, 10.1073/pnas.89.8.3571 De Caterina, 1993, Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids, J. Appl. Physiol., 75, 2368, 10.1152/jappl.1993.75.6.2368 Gerke, 2002, Annexins: from structure to function, Physiol. Rev., 82, 331, 10.1152/physrev.00030.2001 Francis, 1992, Human neutrophil annexin I promotes granule aggregation and modulates Ca2+− dependent membrane fusion, J. Clin. Invest., 90, 537, 10.1172/JCI115892 Goulding, 1990, Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone, Lancet, 335, 1416, 10.1016/0140-6736(90)91445-G Ambrose, 1990, Corticosteroids increase lipocortin I in alveolar epithelial cells, Am. J. Respir. Cell Mol. Biol., 3, 349, 10.1165/ajrcmb/3.4.349 Christmas, 1991, Selective secretion of annexin I, a protein without a signal sequence, by the human prostate gland, J. Biol. Chem., 266, 2499, 10.1016/S0021-9258(18)52272-9 Perretti, 1996, Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration, Nat. Med., 22, 1259, 10.1038/nm1196-1259 Perretti, 2000, Annexin I is stored within gelatinase granules of human neutrophils and mobilised on the cell surface upon adhesion but not phagocytosis, Cell Biol. Int., 24, 163, 10.1006/cbir.1999.0468 Oliani, 2001, Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression, Am. J. Pathol., 158, 603, 10.1016/S0002-9440(10)64002-3 Mancuso, 1995, Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1, J. Immunol., 155, 377 Perretti, 2002, Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor, Nat. Med., 8, 1296, 10.1038/nm786 Perretti, 1994, Lipocortin-derived peptides, Biochem. Pharmacol., 47, 931, 10.1016/0006-2952(94)90402-2 Le, 2002, Formyl-peptide receptors revisited, Trends Immunol., 23, 541, 10.1016/S1471-4906(02)02316-5 Walther, 2000, A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR, Mol. Cell, 5, 831, 10.1016/S1097-2765(00)80323-8 Ernst, 2004, An annexin 1 N-terminal Peptide activates leukocytes by triggering different members of the formyl Peptide receptor family, J. Immunol., 172, 7669, 10.4049/jimmunol.172.12.7669 Solito, 2003, A novel calcium-dependent pro-apoptotic effect of annexin 1 on human neutrophils, FASEB J., 17, 1544, 10.1096/fj.02-0941fje Maderna, 2005, Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2-26, J. Immunol., 174, 3727, 10.4049/jimmunol.174.6.3727 Jozsef, 2002, Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes, Proc. Natl. Acad. Sci. USA, 99, 13266, 10.1073/pnas.202296999 Kenakin, 2002, Efficacy at g protein-coupled receptors, Nat. Rev. (Drug Discovery), 1, 103, 10.1038/nrd722 Migeotte, 2005, Identification and characterization of an endogenous chemotactic ligand specific for FPRL2, J. Exp. Med., 201, 83, 10.1084/jem.20041277 Fierro, 2003, Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells, J. Immunol., 170, 2688, 10.4049/jimmunol.170.5.2688 Srikrishna, 2001, Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells, J. Immunol., 166, 4678, 10.4049/jimmunol.166.7.4678 Lim, 1998, Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1, Proc. Natl. Acad. Sci. USA, 95, 14535, 10.1073/pnas.95.24.14535 Gavins, 2003, Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms, Blood, 101, 4140, 10.1182/blood-2002-11-3411 Cuzzocrea, 1997, Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration, J. Immunol., 159, 5089 D’Amico, 2000, Lipocortin 1 reduces myocardial ischaemia-reperfusion injury by affecting local leukocyte recruitment, FASEB J., 14, 1867, 10.1096/fj.99-0602fje La, 2001, Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action, FASEB J., 15, 2247, 10.1096/fj.01-0196com Gavins, 2005, Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct, FASEB J., 19, 100, 10.1096/fj.04-2178fje Chiang, 1999, Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion, J. Clin. Invest., 104, 309, 10.1172/JCI7016 Gao, 1998, Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse, Genomics, 51, 270, 10.1006/geno.1998.5376 Takano, 1997, Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors, J. Exp. Med., 185, 1693, 10.1084/jem.185.9.1693 Liang, 2000, Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils, Biochem. Biophys. Res. Commun., 270, 331, 10.1006/bbrc.2000.2416 Vaughn, 2002, Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene, J. Immunol., 169, 3363, 10.4049/jimmunol.169.6.3363 Gao, 1999, Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor, J. Exp. Med., 189, 657, 10.1084/jem.189.4.657 Le, 1999, Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation, J. Immunol., 163, 6777 Prossnitz, 1997, The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function, Pharmacol. Ther., 74, 73, 10.1016/S0163-7258(96)00203-3 Perretti, 2001, Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics, Am. J. Pathol., 158, 1969, 10.1016/S0002-9440(10)64667-6 Epstein, 1989, Tissue destruction by neutrophils, N. Engl. J. Med., 320, 365, 10.1056/NEJM198902093200606 Carden, 2000, Pathophysiology of ischaemia-reperfusion injury, J. Pathol., 190, 255, 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6 Lefer, 2002, Do neutrophils contribute to myocardial reperfusion injury?, Basic Res. Cardiol., 97, 263, 10.1007/s00395-002-0363-x Baxter, 2002, The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on, Basic Res. Cardiol., 97, 268, 10.1007/s00395-002-0366-7 Ley, 1995, Gene-targeted mice in leukocyte adhesion research, Microcirculation, 2, 141, 10.3109/10739689509146762 Chiang, 2000, Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation, J. Exp. Med., 191, 1197, 10.1084/jem.191.7.1197 Rabb, 1997, Leukocytes, cell adhesion molecules and ischemic acute renale failure, Kidney Int., 51, 1463, 10.1038/ki.1997.200 Kieran, 2003, Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog, Kidney Int., 64, 480, 10.1046/j.1523-1755.2003.00106.x Ritchie, 2003, Cardioprotective actions of an N-terminal fragment of annexin-1 in rat myocardium in vitro, Eur. J. Pharmacol., 461, 171, 10.1016/S0014-2999(03)01314-1 Becker, 1998, Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells, Cell Tissue Res., 292, 129, 10.1007/s004410051042 Su, 1999, A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells, J. Exp. Med., 189, 395, 10.1084/jem.189.2.395 Le, 2001, Amyloid {beta}42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1, J. Neurosci., 21, RC123, 10.1523/JNEUROSCI.21-02-j0003.2001 Resnati, 2002, The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R, Proc. Natl. Acad. Sci. USA, 99, 1359, 10.1073/pnas.022652999 Harada, 2004, N-Formylated humanin activates both formyl peptide receptor-like 1 and 2, Biochem. Biophys. Res. Commun., 324, 255, 10.1016/j.bbrc.2004.09.046 Wang, 2002, Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice, Gene, 299, 57, 10.1016/S0378-1119(02)01012-0 John, 2001, Does annexin 1 act via the FPR receptor?, J. Endocrinol., 169, P150 Rosengarth, 2001, X-ray structure of full-length annexin 1 and implications for membrane aggregation, J. Mol. Biol., 306, 489, 10.1006/jmbi.2000.4423 Rosengarth, 2003, A calcium-driven conformational switch of the N-terminal and core domains of annexin A1, J. Mol. Biol., 326, 1317, 10.1016/S0022-2836(03)00027-5